Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hycalvit is a nutritional supplement developed by Ultramark Healthcare, typically formulated as a combination of calcium (often in forms such as calcium gluconate and calcium lactate), vitamin D3 (cholecalciferol), and vitamin B12 (cyanocobalamin). It is indicated for the treatment and prevention of deficiencies in these essential nutrients, supporting bone health, nerve function, and red blood cell production. Cholecalciferol enhances calcium absorption via the vitamin D receptor, while calcium provides the structural matrix for bone mineralization. Cyanocobalamin serves as a vital cofactor for DNA synthesis and neurological health. Hycalvit is available in oral forms such as syrups and tablets and is marketed as a branded-generic product in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium + cholecalciferol + cyanocobalamin.